Immunocore Company
Immunocore is a biotechnology company that specializes in the development of TCR bispecific immunotherapies.
Technology:
Cell-based gene therapy, Peptides and Proteins
Industry:
Healthcare, Public
Headquarters:
Abingdon, Oxfordshire, United Kingdom
Founded Date:
2008-01-01
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
13
Total Funding:
808834313
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-07-18
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership